Today's Earnings Calculators Terms of Service Privacy Policy Data Sources Support Mobile app Instagram

StockRay is an AI stock analysis service by Warm Tech Company.

Warm Tech Company | CEO Jinyoung Moon | Reg. 317-27-02126

13, Cheonggyesan-ro 4-gil, Sujeong-gu, Seongnam-si, Gyeonggi-do, Korea | partner@warmtech.company

All information provided by Warm Tech Company is for reference only and does not constitute a recommendation to buy or sell any specific stock. You are solely responsible for your investment decisions.

© 2026 Warm Tech Company. All rights reserved.

HeartBeam, Inc. Stock Price·Forecast · AI Analysis | StockRay

HeartBeam, Inc.

BEAT · Healthcare · $20M

After-hours $0.37-0.54%

2026 Q2 earnings

Price

$0.73

$0.37

Jul 1, 26Sep 29, 26

What's this stock's score right now?

See its score for free — revenue and money flow, graded on one standard.

Quarterly Financials

RevenueOperating IncomeNet Income

9/'26

Revenue$0M

6/'26 vs prev quarter

Company Health

Market Cap$20M

Cash on Hand$9M42.9% of market cap

Free Cash Flow$-14M-69.0% of market cap

Among 15 Medical - Specialties peers

LowMedianHigh

PBR2.5x

median 1.7xROE-248.2%

median -27.2%

HeartBeam, Inc. Letter to ShareholdersSep 21

HeartBeam, Inc. (BEAT) Q2 2026 Earnings Call TranscriptAug 14

HeartBeam Reports Second Quarter 2026 ResultsAug 13

HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern TimeJul 30

HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG DeviceJul 14

Bet On These 5 Top-Ranked Stocks With Increasing P/E RatiosJul 7

Related Stocks

R
Rein Therapeutics Inc.
P
P3 Health Partners Inc.
R
Retractable Technologies, Inc.
E
Evaxion Biotech A/S
B
Burning Rock Biotech Limited
B
Bionano Genomics, Inc.
A
Atossa Therapeutics, Inc.
E
Estrella Immunopharma, Inc.

Daily Prices

09.29$0.37-1.37%

09.28$0.37+3.67%

09.25$0.36-5.07%

09.24$0.38-2.55%

09.23$0.39-10.33%

09.22$0.43+0.63%

09.21$0.43+6.97%

09.18$0.40-4.00%

09.17$0.42+2.52%

09.16$0.41-3.67%

Revenue Breakdown

As of Dec 2019

Source: Company IR filings

MonitoringCommercial49.7%
MonitoringMedicare35.0%
ClinicalTrialSupportandRelatedServices12.4%
TechnologyDevicesConsumablesandRelatedServices2.9%

BusinessMedical - Specialties·heartbeam.com↗

“매출은 25년 3분기부터 26년 2분기까지 계속 0달러지만, 이번 분기에는 미국 4개 지역에서 계약을 맺고 첫 주문을 배송해 ‘개발 단계’에서”

In the company's words · 2026 2분기 earnings call